The gene <i>MAB_2362</i> is responsible for intrinsic resistance to various drugs and virulence in <i>Mycobacterium abscessus</i> by regulating cell division
<i>Mycobacterium abscessus</i> exhibits intrinsic resistance to most antibiotics, hence leading to infections that are difficult to treat. To address this issue, the identification of new molecular targets is essential for the development or repositioning of therapeutic agents. This study demonstrated that the <i>MAB_2362</i>-knockout strain, Mab<sup>Δ2362</sup>, became significantly susceptible to a range of antibiotics, not only <i>in vitro</i> but also exhibited susceptibility to rifabutin, bedaquiline, and linezolid <i>in vivo</i>. While the bacterial burden of the wild-type <i>M. abscessus</i> (Mab<sup>Wt</sup>) increased by over 1 log<sub>10</sub> CFU/lung in a murine infection model 16 days post-infection, that of Mab<sup>Δ2362</sup> strain decreased by more than 1 log<sub>10</sub> CFU/lung, which suggests that the disruption leads to attenuation. Bioinformatics analysis revealed that MAB_2362 shares the highest similarity (41.35%) with SteA, a protein known to influence cell division in <i>Corynebacterium glutamicum</i>, suggesting that MAB_2362 might be involved in cell division. Mab<sup>Δ2362</sup> cells exhibited a median length of 2.62 µm, which was substantially longer than the 1.44 µm recorded for Mab<sup>Wt</sup> cells. Additionally, multiple cell division septa were observed in 42% of Mab<sup>Δ2362</sup> cells, whereas none were seen in Mab<sup>Wt</sup> cells. An ethidium bromide uptake assay further suggested a higher cell envelope permeability in Mab<sup>Δ2362</sup> compared to Mab<sup>Wt</sup>. Collectively, these findings underscore the role of <i>MAB_2362</i> in intrinsic resistance and virulence of <i>M. abscessus</i> possibly through the regulation of cell division. Thus, MAB_2362 emerges as a promising candidate for targeted interventions in the pursuit of novel antimicrobials against <i>M. abscessus</i>.
Authors
- Cuiting Fang (ORCID: https://orcid.org/0000-0002-8045-3098)
- Sanshan Zeng
- Xingli Han
- Yanan Ju
- Xirong Tian (ORCID: https://orcid.org/0000-0003-1184-7875)
- Xinwen Chen (ORCID: https://orcid.org/0000-0002-4052-8155)
- Wanli Ma (ORCID: https://orcid.org/0000-0002-6172-020X)
- Shuai Wang (ORCID: https://orcid.org/0000-0003-0893-2534)
- Tianyu Zhang (ORCID: https://orcid.org/0000-0001-5647-6014)
- Jie Ding (ORCID: https://orcid.org/0000-0002-1427-9618)
- Buhari Yusuf (ORCID: https://orcid.org/0000-0002-4021-4519)
- Lijie Li (ORCID: https://orcid.org/0009-0003-6380-6714)
- Jingran Zhang (ORCID: https://orcid.org/0000-0002-4258-461X)
- Han Zhang (ORCID: https://orcid.org/0009-0000-8542-2509)
Institutions
- University of Science and Technology of China (CN)
- Anhui University (CN)
- Chinese Academy of Sciences (CN)
- Guangzhou Institutes of Biomedicine and Health (CN)
- Guangzhou Experimental Station (CN)
- State Key Laboratory of Respiratory Disease (CN)
Publication Details
- Journal
- Antimicrobial Agents and Chemotherapy
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1128/aac.00433-24
- Citations
- 6
- Primary Topic
- Mycobacterium research and diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 2.32
Funders
- Guangzhou Medical University
- State Key Laboratory of Respiratory Disease
- National Natural Science Foundation of China